« Back
Home /
a5IA 25mg

a5IA 25mg

Item no.	A14343-25
Manufacturer	Adooq
CASRN	215874-86-5
Amount	25 mg
Quantity options	1 mg 10 mg 100 mg 2 mg 25 mg 5 mg 50 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	CC1=CC(=NO1)C2=NN=C3N2N=C(C4=CC=CC=C43)OCC5=CN(N=N5)C
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	CAS-No: 215874-86-5
Similar products	215874-86-5
Available
Storage Conditions	2 years at -20C
Molecular Weight	362, 34546
Chemical Name	3-(5-methylisoxazol-3-yl)-6-[(1-methyl-1H-1, 2, 3-triazol-4-yl)methoxy][1, 2, 4]triazolo[3, 4-a]phthalazine
Description	a5IA is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme.
Solubilty	DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

A14343-25-datasheet.pdf

A14343-25-safety-datasheet.pdf